7,636 reports of this reaction
2.0% of all LANSOPRAZOLE reports
#9 most reported adverse reaction
FATIGUE is the #9 most commonly reported adverse reaction for LANSOPRAZOLE, manufactured by Takeda Pharmaceuticals America, Inc.. There are 7,636 FDA adverse event reports linking LANSOPRAZOLE to FATIGUE. This represents approximately 2.0% of all 389,756 adverse event reports for this drug.
Patients taking LANSOPRAZOLE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for LANSOPRAZOLE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for LANSOPRAZOLE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 7,636 FDA reports for LANSOPRAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.0% of all adverse event reports for LANSOPRAZOLE, making it a notable side effect.
If you experience fatigue while taking LANSOPRAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.